Cite Filings / ABUS / 0001104659-17-060395
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13D/A

Beneficial Ownership Report

Arbutus Biopharma Corp · Filed 2017-10-03 · Acc 0001104659-17-060395

Documents 1

  • SC 13D/A Beneficial Ownership Report , a17-22768_1sc13da.htm

Around this filing

  • 2017-10-17 SC 13D/A Beneficial Ownership Report
  • 2017-10-05 4 Chief Scientific Officer sold 10,000 shares at $8.00 ($80,000)
  • 2017-10-03 8-K Other events
  • 2017-10-03 DEFA14A Proxy Materials
  • 2017-10-03 8-K Material agreement · Unregistered share sale · Other events
  • 2017-10-03 SC 13D/A Beneficial Ownership Report
  • 2017-07-06 SC 13D/A Beneficial Ownership Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · Two Seas Capital LP 4.1%
  2. 2026-11-16 SCHEDULE 13G/A · Whitefort Capital Master Fund, LP 1.6%
  3. 2026-11-16 SCHEDULE 13G · NOMURA HOLDINGS INC 7.3%
  4. 2026-10-05 SCHEDULE 13D/A · Roivant Sciences Ltd. 19.5%
Loading a17-22768_1sc13da.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…